Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 104

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB)

Barros, Caio H. N., Fulaz, Stephanie, Stanisic, Danijela, Tasic, Ljubica · 2018 · Antibiotics

Abstract

Multidrug-resistant bacteria (MDRB) are extremely dangerous and bring a serious threat to health care systems as they can survive an attack from almost any drug. The bacteria’s adaptive way of living with the use of antimicrobials and antibiotics caused them to modify and prevail in hostile conditions by creating resistance to known antibiotics or their combinations. The emergence of nanomaterials as new antimicrobials introduces a new paradigm for antibiotic use in various fields. For example, silver nanoparticles (AgNPs) are the oldest nanomaterial used for bactericide and bacteriostatic purposes. However, for just a few decades these have been produced in a biogenic or bio-based fashion. This review brings the latest reports on biogenic AgNPs in the combat against MDRB. Some antimicrobial mechanisms and possible silver resistance traits acquired by bacteria are also presented. Hopefully, novel AgNPs-containing products might be designed against MDR bacterial infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics7030069

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 162

  1. Littier, 2017, Animal agriculture as a contributor to the global challenge of antibiotic resistance, CAB Rev., 8, 1, 10.1079/PAVSNNR201712003 · doi:10.1079/pavsnnr201712003
  2. Huebner, 2016, Economic burden of multidrug-resistant bacteria in nursing homes in Germany: A cost analysis based on empirical data, BJM Open, 6, e008458
  3. Lane, 2006, Designer combination therapy for cancer, Nat. Biotechnol., 24, 163, 10.1038/nbt0206-163 · DOI
  4. Richman, 2001, HIV chemotherapy, Nature, 410, 995, 10.1038/35073673 · DOI · Paper page
  5. Nosten, 2007, Artemisinin-based combination treatment of falciparum malaria, Am. J. Trop. Med. Hyg., 77, 191, 10.4269/ajtmh.2007.77.181 · DOI · Paper page
  6. Xiao, 2018, Chemo-enzymatic synthesis of poly (4-piperidine lactone-b-ω-pentadecalactone) block copolymers as biomaterials with antibacterial properties, Biomacromolecules, 19, 2673, 10.1021/acs.biomac.8b00296 · DOI
  7. Zoriasatein, 2018, Evaluation of antimicrobial properties of derivative peptide of Naja naja snake’s venom, World Fam. Med. J., 16, 44, 10.5742/MEWFM.2018.93382 · DOI
  8. Hamzah, 2018, Evaluation of Phyllanthus emblica extract as antibacterial and antibiofilm against biofilm formation, TIJAS, 49, 142
  9. Naqvi, 2013, Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria, Int. J. Nanomed., 8, 3187, 10.2147/IJN.S49284 · DOI · Paper page
  10. Sirelkhatim, 2015, Review on zinc oxide nanoparticles: Antibacterial activity, Nano-Micro Lett., 7, 219, 10.1007/s40820-015-0040-x · DOI · Paper page
  11. Ingle, 2014, Bioactivity, mechanism of action, and cytotoxicity of copper-based nanoparticles: A review, Appl. Microbiol. Biotechnol., 98, 1001, 10.1007/s00253-013-5422-8 · DOI · Paper page
  12. Dinali, 2017, Iron oxide nanoparticles in modern microbiology and biotechnology, Crit. Rev. Microb., 43, 493, 10.1080/1040841X.2016.1267708 · DOI · Paper page
  13. Dastjerdi, 2010, A review on the application of inorganic nano-structured materials in the modification of textiles: Focus on anti-microbial properties, Colloids Surf. B Biointerfaces, 79, 5, 10.1016/j.colsurfb.2010.03.029 · DOI · Paper page
  14. Ballottin, 2017, Antimicrobial textiles: Biogenic silver nanoparticles against Candida and Xanthomonas, Mater. Sci. Eng. C, 75, 582, 10.1016/j.msec.2017.02.110 · DOI
  15. Ertem, 2017, Core-shell silver nanoparticles in endodontic disinfection solutions enable long-term antimicrobial effect on oral biofilms, ACS Appl. Mater. Interfaces, 9, 34762, 10.1021/acsami.7b13929 · DOI
  16. Grumezescu, A. (2016). Use of nanoparticles as a potential antimicrobial for food packaging. Food Preservation, Academic Press. [1st ed.].
  17. Holtz, 2012, Nanostructured silver vanadate as a promising antibacterial additive to water-based paints, Nanomed. NBM, 8, 935, 10.1016/j.nano.2011.11.012 · DOI
  18. Rai, 2012, Silver nanoparticles: The powerful nanoweapon against multidrug-resistant bacteria, J. Appl. Microb., 112, 841, 10.1111/j.1365-2672.2012.05253.x · DOI · Paper page
  19. Radetic, 2013, Functionalization of textile materials with silver nanoparticles, J. Mater. Sci., 48, 95, 10.1007/s10853-012-6677-7 · DOI · Paper page
  20. Maneerung, 2008, Impregnation of silver nanoparticles into bacterial cellulose for antimicrobial wound dressing, Carbohydr. Polym., 72, 43, 10.1016/j.carbpol.2007.07.025 · DOI · Paper page
  21. Chen, 2006, Effect of silver nanoparticles dressing on second degree burn wound, Zhonghua Wai Ke Za Zhi, 44, 50
  22. Muangman, 2006, Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds, J. Med. Assoc. Thail., 89, 953
  23. Cohen, 2007, In vitro analysis of a nanocrystalline silver-coated surgical mesh, Surg. Infect., 8, 397, 10.1089/sur.2006.032 · DOI · Paper page
  24. Lansdown, 2006, Silver in health care: Antimicrobial effects and safety in use, Curr. Probl. Dermatol., 33, 17, 10.1159/000093928 · DOI · Paper page
  25. Zhang, 2007, Study on germicidal efficacy and toxicity of compound disinfectant gel of nanometer silver and chlorhexidine acetate, Chin. J. Health Lab. Technol., 17, 1403
  26. Zhang, 2007, A study on the bio-safety for nano-silver as anti-bacterial materials, Chin. J. Med. Instrum., 31, 35
  27. Nowack, 2011, 120 Years of nanosilver history: Implications for policy makers, Environ. Sci. Technol., 45, 1177, 10.1021/es103316q · DOI · Paper page
  28. Waksman, 1973, History of the word ‘antibiotic’, J. Hist. Med. Allied Sci., 28, 284, 10.1093/jhmas/XXVIII.3.284 · DOI
  29. Davies, 2010, Origins and evolution of antibiotic resistance, Microbiol. Mol. Biol. Rev., 74, 417, 10.1128/MMBR.00016-10 · DOI · Paper page
  30. Williams, 2009, The introduction of ‘chemotherapy’ using arsphenamine—The first magic bullet, J. R. Soc. Med., 102, 343, 10.1258/jrsm.2009.09k036 · DOI
  31. Izumi, 2001, Modern Japanese medical history and the European influence, Keio J. Med., 50, 91, 10.2302/kjm.50.91 · DOI
  32. Amivov, 2010, A brief history of the antibiotic era: Lessons learned and challenges for the future, Front. Microbiol., 1, 134
  33. Bbosa, 2014, Antibiotics/antibacterial drug use, their marketing and promotion during the post-antibiotic golden age and their role in emergence of bacterial resistance, Health, 6, 410, 10.4236/health.2014.65059 · DOI
  34. Thal, 1999, Occurrence and epidemiology of resistance to virginiamycin and streptogramins, J. Antimicrob. Chemother., 43, 171, 10.1093/jac/43.2.171 · DOI
  35. Manten, 1969, Development of drug resistance to rifampicin, Chemotherapy, 14, 93, 10.1159/000220615 · DOI
  36. Schönfeld, W., and Kirst, H. (2002). Introduction to the macrolide antibiotics. Macrolide Antibiotics Milestones in Drug Therapy MDT, Birkhäuser. · doi:10.1007/978-3-0348-8105-0
  37. Jacoby, 2005, Mechanisms of resistance to quinolones, Clin. Infect. Dis., 41, S120, 10.1086/428052 · DOI · Paper page
  38. Madhavan, 2013, Farewell, chloramphenicol? Is this true?: A review, J. Microbiol. Biotechnol., 3, 13
  39. Mutnick, 2003, Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program, Ann. Pharmacother., 37, 769, 10.1345/aph.1C437 · DOI
  40. Abraham, 1940, An enzyme from bacteria able to destroy penicillin, Rev. Infect. Dis., 10, 677
  41. Davies, 1995, Vicious circles: Looking back on resistance plasmids, Genetics, 139, 1465, 10.1093/genetics/139.4.1465 · DOI
  42. Funnell, B., and Philips, G. (2004). Introduction to plasmids: A selective view of their history. Plasmid Biology, ASM Press. · doi:10.1128/9781555817732
  43. Hacker, 2000, Pathogenicity islands and the evolution of microbes, Annu. Rev. Microbiol., 54, 641, 10.1146/annurev.micro.54.1.641 · DOI · Paper page
  44. Steward, 2001, Antibiotic resistance of bacteria in biofilms, Lancet, 358, 135, 10.1016/S0140-6736(01)05321-1 · DOI · Paper page
  45. Andersson, 2003, Persistence of antibiotic resistant bacteria, Curr. Opin. Microbiol., 6, 452, 10.1016/j.mib.2003.09.001 · DOI · Paper page
  46. Nikaido, 2009, Multidrug Resistance in Bacteria, Annu. Rev. Biochem., 78, 119, 10.1146/annurev.biochem.78.082907.145923 · DOI · Paper page
  47. Kirbis, 2015, Spread of antibiotic resistant bacteria from food of animal origin to humans and vice versa, Procedia Food Sci., 5, 148, 10.1016/j.profoo.2015.09.043 · DOI
  48. 2015, The Antibiotic Resistance Crisis—Part 1: Causes and Threats, Pharm. Ther., 40, 277
  49. Paterson, 2016, Multidrug resistant bacteria in the community: Trends and lessons learned, Infect. Dis. Clin. N. Am., 30, 377, 10.1016/j.idc.2016.02.004 · DOI · Paper page
  50. Davies, 2006, Where have all the antibiotics gone?, Can. J. Infect. Dis. Med. Microbiol., 17, 287, 10.1155/2006/707296 · DOI · Paper page
  51. (2018, June 10). Why Are There So Few Antibiotics in the Research and Development Pipeline?. Available online: https://www.pharmaceutical-journal.com/news-and-analysis/features/why-are-there-so-few-antibiotics-in-the-research-and-development-pipeline/11130209.article.
  52. Thakkar, 2010, Biological synthesis of metallic nanoparticles, Nanomed. NBM, 6, 257, 10.1016/j.nano.2009.07.002 · DOI · Paper page
  53. Silveira, 2015, Silver nanoparticle protein corona and toxicity: A mini-review, J. Nanobiotechnol., 13, 1
  54. Ballottin, 2016, Elucidating protein involvement in the stabilization of the biogenic silver nanoparticles, Nanoscale Res. Lett., 11, 1, 10.1186/s11671-016-1538-y · DOI
  55. Shannahan, 2014, Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors, Toxicol. Sci., 143, 136, 10.1093/toxsci/kfu217 · DOI · Paper page
  56. Rai, M., and Bridge, P.D. (2009). Myconanotechnology: A new and emerging science. Applied Mycology, CABI. · doi:10.1079/9781845935344.0000
  57. Zhao, 2017, Fungal silver nanoparticles: Synthesis, application and challenges, Crit. Rev. Biotechnol., 38, 817, 10.1080/07388551.2017.1414141 · DOI · Paper page
  58. Ahmad, 2003, Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum, Colloids Surf. B, 28, 313, 10.1016/S0927-7765(02)00174-1 · DOI · Paper page
  59. Marcato, 2005, Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains, J. Nanobiotechnol., 3, 8, 10.1186/1477-3155-3-8 · DOI · Paper page
  60. Scandorieiro, 2016, Synergistic and additive effect of oregano essential oil and biological silver nanoparticles against multidrug-resistant bacterial strains, Front. Microbiol., 7, 760, 10.3389/fmicb.2016.00760 · DOI · Paper page
  61. Graves, 2015, Rapid evolution of silver nanoparticle resistance in Escherichia coli, Front. Genet., 6, 42, 10.3389/fgene.2015.00042 · DOI · Paper page
  62. Chowdhury, 2014, Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria, Nanoscale Res. Lett., 9, 365, 10.1186/1556-276X-9-365 · DOI
  63. Neethu, 2018, Green synthesized silver nanoparticles by marine endophytic fungus Penicillium polonicum and its antibacterial efficacy against biofilm forming, multidrug-resistant Acinetobacter baumanii, Microb. Pathog., 116, 263, 10.1016/j.micpath.2018.01.033 · DOI · Paper page
  64. Gopinath, 2015, Mycosynthesis, characterization and antibacterial properties of AgNPs against multidrug resistant (MDR) bacterial pathogens of female infertility cases, Asian J. Pharm. Sci., 10, 138, 10.1016/j.ajps.2014.08.007 · DOI
  65. Fayaz, 2010, Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: A study against gram-positive and gram-negative bacteria, Nanomed. NBM, 6, 103, 10.1016/j.nano.2009.04.006 · DOI · Paper page
  66. Bhat, 2015, Exploitation of filamentous fungi for biosynthesis of silver nanoparticle and its enhanced antibacterial activity, Int. J. Pharm. Biol. Sci., 6, 506
  67. Ray, 2011, Extracellular biosynthesis of silver nanoparticles using the mycorrhizal mushroom Tricholoma crassum (Berk.) SACC: Its antimicrobial activity against pathogenic bacteria and fungus, including multidrug resistant plant and human bacteria, Dig. J. Nanomater. Biostruct., 6, 1289
  68. Dhanasekaran, 2013, Extracellular biosynthesis, characterisation and in-vitro antibacterial potential of silver nanoparticles using Agaricus bisporus, J. Exp. Nanosci., 8, 579, 10.1080/17458080.2011.577099 · doi:10.1080/17458080.2011.577099
  69. Saravanan, 2010, Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE, Colloids Surf. B Biointerfaces, 77, 214, 10.1016/j.colsurfb.2010.01.026 · doi:10.1016/j.colsurfb.2010.01.026
  70. Dar, 2013, Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics, Nanomed. NBM, 9, 105, 10.1016/j.nano.2012.04.007 · DOI · Paper page
  71. Hiremath, 2014, Antibacterial activity of silver nanoparticles from Rhizopus spp against Gram negative E. coli-MDR strains, J. Pure Appl. Microbiol., 8, 555
  72. Singh, 2015, Bacteriagenic silver nanoparticles: Synthesis, mechanism, and applications, Appl. Microbiol. Biotechnol., 99, 4579, 10.1007/s00253-015-6622-1 · DOI · Paper page
  73. Saifuddin, 2009, Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation, E-J. Chem., 6, 61, 10.1155/2009/734264 · DOI · Paper page
  74. Zhang, 2016, Light-induced reduction of silver ions to silver nanoparticles in aquatic environments by microbial extracellular polymeric substances (EPS), Water Res., 106, 242, 10.1016/j.watres.2016.10.004 · doi:10.1016/j.watres.2016.10.004
  75. Klaus, 1999, Silver-based crystalline nanoparticles, microbially fabricated, Proc. Natl. Acad. Sci. USA, 96, 13611, 10.1073/pnas.96.24.13611 · DOI · Paper page
  76. Joerger, 2001, Bacteria as workers in the living factory: Metal-accumulating bacteria and their potential for materials science, Trends Biotechnol., 19, 15, 10.1016/S0167-7799(00)01514-6 · DOI · Paper page
  77. Kalishwaralal, 2010, Biosynthesis of silver and gold nanoparticles using Brevibacterium casei, Colloids Surf. B, 77, 257, 10.1016/j.colsurfb.2010.02.007 · DOI · Paper page
  78. Singh, 2017, Biosynthesis of silver nanoparticles using Aeromonas sp. THG-FG1.2 and its antibacterial activity against pathogenic microbes, Artif. Cells Nanomed. Biotechnol., 45, 584, 10.3109/21691401.2016.1163715 · DOI
  79. Desai, 2016, Hydrothermal assisted biosynthesis of silver nanoparticles from Streptomyces sp. GUT 21 (KU500633) and its therapeutic antimicrobial activity, J. Nanostruct. Chem., 6, 235, 10.1007/s40097-016-0197-y · doi:10.1007/s40097-016-0197-y
  80. Manikprabhu, 2016, Sunlight mediated synthesis of silver nanoparticles by a novel actinobacterium (Sinomonas mesophila MPKL 26) and its antimicrobial activity against multi drug resistant Staphylococcus aureus, J. Photochem. Photobiol., 158, 202, 10.1016/j.jphotobiol.2016.01.018 · doi:10.1016/j.jphotobiol.2016.01.018
  81. Santos, K.S., Barbosa, A.M., Costa, L.P., Pinheiro, M.S., Oliveira, M.B.P.P., and Padilha, F.F. (2016). Silver nanocomposite biosynthesis: Antibacterial activity against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Molecules, 21. · DOI
  82. Subashini, 2014, Anti-ESBL activity of silver nanoparticles biosynthesized using soil Streptomyces species, Bioprocess Biosyst. Eng., 37, 999, 10.1007/s00449-013-1070-8 · DOI
  83. Thomas, 2014, Antibacterial activity and synergistic effect of biosynthesized AgNPs with antibiotics against multidrug-resistant biofilm-forming coagulase-negative Staphylococci isolated from clinical samples, Appl. Biochem. Biotechnol., 173, 449, 10.1007/s12010-014-0852-z · DOI
  84. Arul, 2017, Antibacterial efficacy of silver nanoparticles and ethyl acetate’s metabolites of the potent halophilic (marine) bacterium, Bacillus cereus A30 on multidrug resistant bacteria, Pathog. Glob. Health, 111, 367, 10.1080/20477724.2017.1390829 · DOI
  85. Lateef, 2015, Biogenic synthesis of silver nanoparticles using cell-free extract of Bacillus safensis LAU 13: Antimicrobial, free radical scavenging and larvicidal activities, Biologia, 70, 1295, 10.1515/biolog-2015-0164 · doi:10.1515/biolog-2015-0164
  86. Jain, 2010, Novel microbial route to synthesize silver nanoparticles using spore crystal mixture of Bacillus thuringiensis, Indian J. Exp. Biol., 48, 1152
  87. Singh, 2014, Green synthesis of silver nanoparticles using cell extracts of Anabaena doliolum and screening of its antibacterial and antitumor activity, J. Microbiol. Biotechnol., 24, 1354, 10.4014/jmb.1405.05003 · DOI
  88. Saravanan, 2011, Rapid biosynthesis of silver nanoparticles from Bacillus megaterium (NCIM 2326) and their antibacterial activity on multi drug resistant clinical pathogens, Colloids Surf. B Biointerfaces, 88, 325, 10.1016/j.colsurfb.2011.07.009 · DOI · Paper page
  89. Priyadarshini, 2013, Synthesis of anisotropic silver nanoparticles using novel strain, Bacillus flexus and its biomedical application, Colloids Surf. B Biointerfaces, 102, 232, 10.1016/j.colsurfb.2012.08.018 · DOI · Paper page
  90. Saravanan, 2018, Synthesis of silver nanoparticles from Bacillus brevis (NCIM 2533) and their antibacterial activity against pathogenic bacteria, Microb. Pathog., 116, 221, 10.1016/j.micpath.2018.01.038 · DOI · Paper page
  91. Ahmed, 2016, A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise, J. Adv. Res., 7, 17, 10.1016/j.jare.2015.02.007 · DOI · Paper page
  92. Prathna, 2011, Biomimetic synthesis of silver nanoparticles by Citrus limon (lemon) aqueous extract and theoretical prediction of particle size, Colloids Surf. B Biointerfaces, 82, 152, 10.1016/j.colsurfb.2010.08.036 · DOI · Paper page
  93. Jiang, 2010, Role of citric acid in the formation of silver nanoplates through a synergistic reduction approach, Langmuir, 26, 4400, 10.1021/la903470f · DOI · Paper page
  94. Makarov, 2014, Green nanotechnologies: Synthesis of metal nanoparticles using plants, Acta Naturae, 6, 35, 10.32607/20758251-2014-6-1-35-44 · DOI · Paper page
  95. Singh, 2010, Biosynthesis of gold and silver nanoparticles by natural precursor clove and their functionalization with amine group, J. Nanopart. Res., 12, 1667, 10.1007/s11051-009-9835-3 · DOI · Paper page
  96. Barros, 2018, Bio-based synthesis of silver nanoparticles from orange waste: Effects of distinct biomolecule coatings on size, morphology, and antimicrobial activity, Nanotechnol. Sci. Appl., 11, 1, 10.2147/NSA.S156115 · DOI
  97. Ma, 2017, Antibacterial evaluation of silver nanoparticles synthesized by polysaccharides from Astragalus membranaceus roots, Biomed. Pharmacother., 89, 351, 10.1016/j.biopha.2017.02.009 · DOI
  98. Anjum, 2016, Biomimetic synthesis of antimicrobial silver nanoparticles using in vitro-propagated plantlets of a medicinally important endangered species: Phlomis bracteosa, Int. J. Nanomed., 11, 1663
  99. Jeeva, 2012, Caesalpinia coriaria leaf extracts mediated biosynthesis of metallic silver nanoparticles and their antibacterial activity against clinically isolated pathogens, Ind. Crops Prod., 52, 714, 10.1016/j.indcrop.2013.11.037 · DOI
  100. Jinu, 2017, Biofabrication of cubic phase silver nanoparticles loaded with phytochemicals from Solanum nigrum leaf extracts for potential antibacterial, antibiofilm and antioxidant activities against MDR human pathogens, J. Clust. Sci., 28, 489, 10.1007/s10876-016-1125-5 · DOI
  101. Prasannaraj, 2017, Enhanced antibacterial, anti-biofilm and antioxidant (ROS) activities of biomolecules engineered silver nanoparticles against clinically isolated Gram positive and Gram negative microbial pathogens, J. Clust. Sci., 28, 645, 10.1007/s10876-017-1160-x · DOI
  102. Das, 2017, Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage, Arab. J. Chem., 10, 862, 10.1016/j.arabjc.2015.08.008 · DOI
  103. Gopinath, 2013, Biogenic synthesis of antibacterial silver chloride nanoparticles using leaf extracts of Cissus quadrangularis Linn, Mater. Lett., 91, 224, 10.1016/j.matlet.2012.09.102 · doi:10.1016/j.matlet.2012.09.102
  104. Khalil, 2014, Green synthesis of silver nanoparticles using olive leaf extract and its antibacterial activity, Arab. J. Chem., 7, 1131, 10.1016/j.arabjc.2013.04.007 · DOI · Paper page
  105. Singh, 2014, Green silver nanoparticles of Phyllanthus amarus: As an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa, J. Nanobiotechnol., 12, 40, 10.1186/s12951-014-0040-x · DOI
  106. Kasithevar, 2017, Antibacterial efficacy of silver nanoparticles against multi-drug resistant clinical isolates from post-surgical wound infections, Microb. Pathog., 107, 327, 10.1016/j.micpath.2017.04.013 · doi:10.1016/j.micpath.2017.04.013
  107. Gopinath, 2012, Biosynthesis of silver nanoparticles from Tribulus terrestris and its antimicrobial activity: A novel biological approach, Colloids Surf. B Biointerfaces, 96, 69, 10.1016/j.colsurfb.2012.03.023 · DOI · Paper page
  108. Veerasamy, 2011, Biosynthesis of silver nanoparticles using mangosteen leaf extract and evaluation of their antimicrobial activities, J. Saudi Chem. Soc., 15, 113, 10.1016/j.jscs.2010.06.004 · DOI
  109. Singh, 2012, Biosynthesis of silver nanoparticles using Ricinus communis L. leaf extract and its antibacterial activity, Dig. J. Nanomater. Biostruct., 7, 1157
  110. Prakash, 2013, Green synthesis of silver nanoparticles from leaf extract of Mimusops elengi, Linn. for enhanced antibacterial activity against multi drug resistant clinical isolates, Colloids Surf. B Biointerfaces, 108, 255, 10.1016/j.colsurfb.2013.03.017 · doi:10.1016/j.colsurfb.2013.03.017
  111. Garg, 2017, In vitro antibacterial activity of biosynthesized silver nanoparticles from ethyl acetate extract of Hydrocotyle sibthorpioides against multidrug resistant microbes, Asian J. Pharm. Clin. Res., 10, 263, 10.22159/ajpcr.2017.v10i6.17976 · doi:10.22159/ajpcr.2017.v10i6.17976
  112. Li, 2017, Making good use of the byproducts of cultivation: Green synthesis and antibacterial effects of silver nanoparticles using the leaf extract of blueberry, J. Food Sci. Technol., 54, 3569, 10.1007/s13197-017-2815-1 · doi:10.1007/s13197-017-2815-1
  113. Miri, 2015, Plant-mediated biosynthesis of silver nanoparticles using Prosopis farcta extract and its antibacterial properties, Spectrochim. Acta A Mol. Biomol. Spectrosc., 141, 287, 10.1016/j.saa.2015.01.024 · DOI
  114. Das, 2013, Sesbania grandiflora leaf extract mediated green synthesis of antibacterial silver nanoparticles against selected human pathogens, Spectrochim. Acta A Mol. Biomol. Spectrosc., 104, 265, 10.1016/j.saa.2012.11.075 · DOI
  115. Lateef, 2016, Biogenic synthesis of silver nanoparticles using a pod extract of Cola nitida: Antibacterial and antioxidant activities and application as a paint additive, J. Taibah Univ. Sci., 10, 551, 10.1016/j.jtusci.2015.10.010 · DOI · Paper page
  116. Kagithoju, 2015, Eco-friendly and green synthesis of silver nanoparticles using leaf extract of Strychnos potatorum Linn.F. and their bactericidal activities, 3 Biotech, 5, 709, 10.1007/s13205-014-0272-3 · doi:10.1007/s13205-014-0272-3
  117. Prabakar, 2013, Evaluation of antibacterial efficacy of phyto fabricated silver nanoparticles using Mukia scabrella (Musumusukkai) against drug resistance nosocomial gram negative bacterial pathogens, Colloids Surf. B Biointerfaces, 104, 282, 10.1016/j.colsurfb.2012.11.041 · doi:10.1016/j.colsurfb.2012.11.041
  118. Meva, 2017, Natural substances for the synthesis of silver nanoparticles against Escherichia coli: The case of Megaphrynium macrostachyum (Marantaceae), Corchorus olitorus (Tiliaceae), Ricinodendron heudelotii (Euphorbiaceae), Gnetum bucholzianum (Gnetaceae), and Ipomoea batatas (Convolvulaceae), J. Nanomater., 2017, 6834726
  119. Shruthi, 2017, Green synthesis of biologically active silver nanoparticles through a phyto-mediated approach using Areca catechu leaf extract, ChemistrySelect, 2, 10354, 10.1002/slct.201702257 · doi:10.1002/slct.201702257
  120. Azeez, 2017, Biomedical applications of cocoa bean extract-mediated silver nanoparticles as antimicrobial, larvicidal and anticoagulant agents, J. Clust. Sci., 28, 149, 10.1007/s10876-016-1055-2 · DOI
  121. Lateef, 2016, Cocoa pod husk extract-mediated biosynthesis of silver nanoparticles: Its antimicrobial, antioxidant and larvicidal activities, J. Nanostruct. Chem., 6, 159, 10.1007/s40097-016-0191-4 · doi:10.1007/s40097-016-0191-4
  122. Swamy, 2015, Synthesis and characterization of silver nanoparticles using fruit extract of Momordica cymbalaria and assessment of their in vitro antimicrobial, antioxidant and cytotoxicity activities, Spectrochim. Acta A Mol. Biomol. Spectrosc., 151, 939, 10.1016/j.saa.2015.07.009 · DOI · Paper page
  123. Jesus, 2016, Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity, Nanomed. NBM, 12, 789, 10.1016/j.nano.2015.11.016 · DOI · Paper page
  124. Li, 2008, Antimicrobial nanomaterials for water disinfection and microbial control: Potential applications and implications, Water Res., 42, 4591, 10.1016/j.watres.2008.08.015 · DOI · Paper page
  125. Manke, 2013, Mechanisms of nanoparticle-induced oxidative stress and toxicity, BioMed Res. Int., 2013, 942916, 10.1155/2013/942916 · DOI · Paper page
  126. Siddiqi, 2018, A review on biosynthesis of silver nanoparticles and their biocidal properties, J. Nanobiotechnol., 16, 14, 10.1186/s12951-018-0334-5 · DOI · Paper page
  127. Zheng, 2018, Antimicrobial silver nanomaterials, Coord. Chem. Rev., 357, 1, 10.1016/j.ccr.2017.11.019 · DOI · Paper page
  128. Lok, 2006, Proteomic analysis of the mode of antibacterial action of silver nanoparticles, J. Proteome Res., 5, 916, 10.1021/pr0504079 · DOI · Paper page
  129. Xiu, 2012, Negligible particle-specific antibacterial activity of silver nanoparticles, Nano Lett., 12, 4271, 10.1021/nl301934w · DOI · Paper page
  130. Dibrov, 2002, Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae, Antimicrob. Agents Chemother., 46, 2668, 10.1128/AAC.46.8.2668-2670.2002 · DOI · Paper page
  131. Liau, 1997, Interaction of silver nitrate with readily identifiable groups: Relationship to the antibacterial action of silver ions, Lett. Appl. Microbiol., 25, 279, 10.1046/j.1472-765X.1997.00219.x · DOI · Paper page
  132. Liao, 2017, Targeting the thioredoxin reductase–thioredoxin system from Staphylococcus aureus by silver ions, Inorg. Chem., 56, 14823, 10.1021/acs.inorgchem.7b01904 · DOI
  133. Holt, 2005, Interaction of silver(I) ions with the respiratory chain of Escherichia coli: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+, Biochemistry, 44, 13214, 10.1021/bi0508542 · DOI · Paper page
  134. Wen, 2013, Binding of cytoskeletal proteins with silver nanoparticles, RSC Adv., 3, 22002, 10.1039/c3ra43281e · DOI
  135. Hong, 2016, Shape effect on the antibacterial activity of silver nanoparticles synthesized via a microwave-assisted method, Environ. Sci. Pollut. Res., 23, 4489, 10.1007/s11356-015-5668-z · DOI · Paper page
  136. Alshareef, 2017, Shape-dependent antibacterial activity of silver nanoparticles on Escherichia coli and Enterococcus faecium bacterium, Appl. Surf. Sci., 424, 310, 10.1016/j.apsusc.2017.03.176 · DOI
  137. Pal, 2007, Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli, Appl. Environ. Microb., 73, 1712, 10.1128/AEM.02218-06 · DOI · Paper page
  138. Acharya, 2018, Shape dependent physical mutilation and lethal effects of silver nanoparticles on bacteria, Sci. Rep., 8, 201, 10.1038/s41598-017-18590-6 · DOI · Paper page
  139. Ivask, A., Kurvet, I., Kasemets, K., Blinova, I., Aruoja, V., Suppi, S., Vija, H., Kakinen, A., Titma, T., and Heinlaan, M. (2014). Size-dependent toxicity of silver nanoparticles to bacteria, yeast, algae, crustaceans and mammalian cells in vitro. PLoS ONE, 9. · DOI · Paper page
  140. Kumari, 2017, Tailoring shape and size of biogenic silver nanoparticles to enhance antimicrobial efficacy against MDR bacteria, Microb. Pathog., 105, 346, 10.1016/j.micpath.2016.11.012 · doi:10.1016/j.micpath.2016.11.012
  141. Lu, 2013, Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria, J. Mater. Sci. Mater. Med., 24, 1465, 10.1007/s10856-013-4894-5 · DOI · Paper page
  142. Chen, 2011, Antimicrobial activity and the mechanism of silver, Int. J. Nanomed., 6, 2873
  143. Kora, 2018, Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cytotoxicity and its mode of action, Arab. J. Chem., 11, 313, 10.1016/j.arabjc.2014.10.036 · DOI
  144. Kim, 2007, Antimicrobial effects of silver nanoparticles, Nanomed. NBM, 3, 95, 10.1016/j.nano.2006.12.001 · DOI · Paper page
  145. Choi, 2008, Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria, Environ. Sci. Technol., 42, 4583, 10.1021/es703238h · DOI · Paper page
  146. Li, 2010, Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli, Appl. Microbiol. Biotechnol., 85, 1115, 10.1007/s00253-009-2159-5 · DOI · Paper page
  147. Ahmad, 2017, The effects of bacteria-nanoparticles interface on the antibacterial activity of green synthesized silver nanoparticles, Microb. Pathog., 102, 133, 10.1016/j.micpath.2016.11.030 · DOI · Paper page
  148. Qayyum, S., Oves, M., and Khan, A.U. (2017). Obliteration of bacterial growth and biofilm through ROS generation by facilely synthesized green silver nanoparticles. PLoS ONE, 12. · DOI · Paper page
  149. Pareek, 2018, Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review, Mater. Sci. Eng. C, 90, 739, 10.1016/j.msec.2018.04.093 · DOI · Paper page
  150. Mchugh, 1975, Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin, Lancet, 1, 235, 10.1016/S0140-6736(75)91138-1 · DOI · Paper page
  151. Gupta, 1999, Molecular basis for resistance to silver cations in Salmonella, Nat. Med., 5, 183, 10.1038/5545 · DOI · Paper page
  152. Finley, 2015, Unprecedented silver resistance in clinically isolated Enterobacteriaceae: Major implications for burn and wound management, Antimicrob. Agents Chemother., 59, 4734, 10.1128/AAC.00026-15 · doi:10.1128/aac.00026-15
  153. Li, 1997, Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins, J. Bacteriol., 179, 6127, 10.1128/jb.179.19.6127-6132.1997 · DOI · Paper page
  154. Randall, 2015, Silver resistance in Gram-negative bacteria: A dissection of endogenous and exogenous mechanisms, J. Antimicrob. Chemother., 70, 1037, 10.1093/jac/dku523 · DOI · Paper page
  155. Su, 2011, Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli, Nature, 470, 558, 10.1038/nature09743 · DOI · Paper page
  156. Xue, 2008, Cu(I) recognition via cation-π and methionine interactions in CusF, Nat. Chem. Biol., 4, 107, 10.1038/nchembio.2007.57 · DOI · Paper page
  157. Gudipaty, 2014, The histidine kinase CusS senses silver ions through direct binding by its sensor domain, Biochim. Biophys. Acta, 1844, 1656, 10.1016/j.bbapap.2014.06.001 · DOI
  158. Franke, 2001, The product of the ybdE gene of the Escherichia coli chromosome is involved in detoxification of silver ions, Microbiology, 147, 965, 10.1099/00221287-147-4-965 · DOI · Paper page
  159. Prucek, 2018, Bacterial resistance to silver nanoparticles and how to overcome it, Nat. Nanotechnol., 13, 65, 10.1038/s41565-017-0013-y · DOI · Paper page
  160. Liang, 2016, Novel asymmetric wettable AgNPs/chitosan wound dressing: In vitro and in vivo evaluation, ACS Appl. Mater. Interfaces, 8, 3958, 10.1021/acsami.5b11160 · DOI · Paper page
  161. Yabanoglu, 2013, Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats, Int. Surg., 98, 416, 10.9738/INTSURG-D-13-00017.1 · doi:10.9738/intsurg-d-13-00017.1
  162. Huang, 2007, A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis, Burns, 33, 161, 10.1016/j.burns.2006.06.020 · DOI · Paper page

Cited by

See all 104

Metadata

Authors
Barros, C. H. N., Fulaz, S., Stanisic, D., & Tasic, L.
Venue
Antibiotics
Publisher
MDPI AG
Published
2018-08-02
Volume
7
Issue
3
Pages
69
ISSN
2079-6382
Cited by
104
References
6
Language
en
Funders
  • Fundação de Amparo à Pesquisa de São Paulo (2015/12534-5 and 2014/50867-3)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (465389/201407)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB). https://app.cochat.ai/papers/10.3390/antibiotics7030069
The paper
Barros, C. H. N., Fulaz, S., Stanisic, D., & Tasic, L. (2018). Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB). Antibiotics. https://doi.org/10.3390/antibiotics7030069

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.